Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI

Xiaowen Yu1,2,3, Man Xu1,2,3, Xia Meng1,2,3

  • 1Department of Nephrology, Children's Hospital of Nanjing Medical University, Nanjing 210008, China.

Insights

Activating pregnane X receptor (PXR) protects against acute kidney injury (AKI) by targeting AKR1B7 to improve mitochondrial function. Disabling this pathway worsens kidney injury, suggesting therapeutic potential.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Biochemistry

Background:

  • Acute kidney injury (AKI) is a significant global health issue lacking effective treatments.
  • The role of the nuclear pregnane X receptor (PXR) in kidney injury is not well understood.
  • PXR is implicated in various diseases, including metabolic disorders and liver injury.

Purpose of the Study:

  • To investigate the role of PXR in the development and progression of AKI.
  • To elucidate the underlying molecular mechanisms of PXR's function in kidney injury.
  • To explore PXR as a potential therapeutic target for AKI.

Main Methods:

  • Analysis of PXR expression in human and animal AKI models.
  • In vivo studies involving PXR silencing and activation in rat models of AKI (cisplatin and ischemia/reperfusion).
  • Luciferase reporter assays, genomic manipulation, and proteomics to identify PXR targets.
  • Assessment of mitochondrial function and renal dysfunction.

Main Results:

  • PXR expression was significantly downregulated in kidneys affected by AKI.
  • PXR silencing exacerbated cisplatin-induced AKI and mitochondrial damage.
  • PXR activation demonstrated a protective effect against AKI.
  • PXR was identified to target Aldo-keto reductase family 1, member B7 (AKR1B7), enhancing mitochondrial function.
  • Restoration of the PXR/AKR1B7/mitochondrial metabolism axis ameliorated kidney injury in both cisplatin and ischemia/reperfusion models.

Conclusions:

  • The PXR/AKR1B7/mitochondrial metabolism axis plays a crucial role in protecting against AKI.
  • Downregulation of this axis contributes to AKI pathogenesis.
  • Re-establishing the PXR/AKR1B7 pathway offers a promising therapeutic strategy for AKI.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.1K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.9K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.0K
Nuclear Export01:42

Nuclear Export

The nucleus restricts several proteins within and allows others to pass. The restricted proteins possess a nuclear retention sequence or NRS, anchoring them to the nuclear lamins and preventing their transport to the cytosol. The non-restricted proteins, after their synthesis, are transported to their site of action, such as the cytosol or other organelles, with the help of nuclear export signals or NES.
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
4.7K